1 INTRODUCTION
1.1 MARKET SEGMENTATION

2 RESEARCH METHODOLOGY
2.1 ECOSYSTEM OF VATENIARY ANIMAL VACCINES MARKET
2.2 TOP-DOWN APPROACH
2.3 BOTTOM-UP APPROACH
2.4 ASSUMPTIONS

3 EXECUTIVE SUMMARY
3.1 GLOBAL VATENIARY ANIMAL VACCINES MARKET SNAPSHOT
3.2 GLOBAL VATENIARY ANIMAL VACCINES MARKET REVENUE, 2017– 2025(US$ MN)

4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 KEY TRENDS ANALYSIS
4.3 PRODUCT DEVELOPMENT AND DIVERSIFICATION ANALYSIS
4.4 PORTERS FIVE FORCE ANALYSIS
4.5 VALUE CHAIN ANALYSIS
4.6 COMPETITIVE LANDSCAPE
4.7 COMPANY MARKET SHARE ANALYSIS
4.8 EXPANSION STRATEGIES ADOPTED BY LEADING PLAYERS

5 GLOBAL VATENIARY ANIMAL VACCINES MARKET, BY TYPE
5.1 OVERVIEW
5.2 MONOVALENT VACCINES
5.3 MULTIVALENT VACCINES
5.4 PROCINE VACCINES
5.5 POULTRY VACCINES
5.6 LIVESTOCK VACCINES
5.6.1 BOVINE VACCINES
5.6.2 SMALL RUMINANT VACCINES
5.7 COMPANION ANIMAL VACCINES
5.7.1 CANINE VACCINES
5.7.2 FENINE VACCINES
5.8 AQUACULTURE VACCINES
5.9 OTHER ANIMAL VACCINES

6 GLOBAL VATENIARY ANIMAL VACCINES MARKET, BY DISEASE
6.1 OVERVIEW
6.2 PORCINE
6.3 LIVESTOCK
6.3.1 BOVINE
6.3.2 SMALL RUMINANT
6.4 COMPANION ANIMAL DISEASE
6.4.1 CANINE
6.4.2 FENINE
6.5 AQUACULTURE
6.6 INFLUENZA
6.7 DENGUE
6.8 ROTAVIRUS
6.9 HEPATITIS
6.10 OTHERS

7 GLOBAL VATENIARY ANIMAL VACCINES MARKET, BY END-USER
7.1 OVERVIEW
7.2 PEDIATRICS
7.3 ADULTS

8 GLOBAL VATENIARY ANIMAL VACCINES MARKET, BY TECHNOLOGY
8.1 OVERVIEW
8.2 LIVE ATTENUATED VACCINES
8.3 INACTIVATED VACCINES
8.4 TOXOID VACCINES
8.5 RECOMBINANT VACCINES
8.6 OTHER VACCINES

9 GLOBAL VATENIARY ANIMAL VACCINES MARKET, BY GEOGRAPHY
9.1 NORTH AMERICA
9.1.1 MARKET DYNAMICS
9.1.1.1 DRIVERS
9.1.1.2 RESTRAINTS
9.1.1.3 OPPORTUNITY
9.1.2 U.S.
9.1.3 CANADA
9.1.4 MEXICO
9.2 EUROPE
9.2.1 MARKET DYNAMICS
9.2.1.1 DRIVERS
9.2.1.2 RESTRAINTS
9.2.1.3 OPPORTUNITY
9.2.2 U.K.
9.2.3 FRANCE
9.2.4 GERMANY
9.2.5 SPAIN
9.2.6 REST OF EUROPE
9.3 ASIA PACIFIC
9.3.1 MARKET DYNAMICS
9.3.1.1 DRIVERS
9.3.1.2 RESTRAINTS
9.3.1.3 OPPORTUNITY
9.3.2 INDIA
9.3.3 CHINA
9.3.4 JAPAN
9.3.5 REST OF ASIA PACIFIC
9.4 MIDDLE EAST AND AFRICA
9.4.1 MARKET DYNAMICS
9.4.1.1 DRIVERS
9.4.1.2 RESTRAINTS
9.4.1.3 OPPORTUNITY
9.4.2 SOUTH AFRICA
9.4.3 REST OF MIDDLE EAST AND AFRICA
9.5 LATIN AMERICA
9.5.1 MARKET DYNAMICS
9.5.1.1 DRIVERS
9.5.1.2 RESTRAINTS
9.5.1.3 OPPORTUNITY
9.5.2 BRAZIL
9.5.3 REST OF LATIN AMERICA

10 GLOBAL VATENIARY ANIMAL VACCINES MARKET, BY COMPANY
10.1 INTRODUCTION
10.2 PFIZER, INC
10.2.1 BUSINESS OVERVIEW
10.2.2 PRODUCTS & SERVICES
10.2.3 KEY STRATEGY
10.2.4 RECENT DEVELOPMENTS
10.2.5 SWOT ANALYSIS
10.3 GLAXOSMITHKLINE PLC.
10.3.1 BUSINESS OVERVIEW
10.3.2 PRODUCTS & SERVICES
10.3.3 KEY STRATEGY
10.3.4 RECENT DEVELOPMENTS
10.3.5 SWOT ANALYSIS
10.4 MERCK AND CO., INC.
10.4.1 BUSINESS OVERVIEW
10.4.2 PRODUCTS & SERVICES
10.4.3 KEY STRATEGY
10.4.4 RECENT DEVELOPMENTS
10.4.5 SWOT ANALYSIS
10.5 SANOFI PASTEUR SA
10.5.1 BUSINESS OVERVIEW
10.5.2 PRODUCTS & SERVICES
10.5.3 KEY STRATEGY
10.5.4 RECENT DEVELOPMENTS
10.5.5 SWOT ANALYSIS
10.6 CSL LIMITED
10.6.1 BUSINESS OVERVIEW
10.6.2 PRODUCTS & SERVICES
10.6.3 KEY STRATEGY
10.6.4 RECENT DEVELOPMENTS
10.6.5 SWOT ANALYSIS
10.7 EMERGENT BIOSOLUTIONS, INC
10.7.1 BUSINESS OVERVIEW
10.7.2 PRODUCTS & SERVICES
10.7.3 KEY STRATEGY
10.7.4 RECENT DEVELOPMENTS
10.7.5 SWOT ANALYSIS
10.8 JOHNSON AND JOHNSON
10.8.1 BUSINESS OVERVIEW
10.8.2 PRODUCTS & SERVICES
10.8.3 KEY STRATEGY
10.8.4 RECENT DEVELOPMENTS
10.8.5 SWOT ANALYSIS
10.9 MEDIMMUNE, LLC
10.9.1 BUSINESS OVERVIEW
10.9.2 PRODUCTS & SERVICES
10.9.3 KEY STRATEGY
10.9.4 RECENT DEVELOPMENTS
10.9.5 SWOT ANALYSIS
10.10 ATELLAS PHARMA, INC
10.10.1 BUSINESS OVERVIEW
10.10.2 PRODUCTS & SERVICES
10.10.3 KEY STRATEGY
10.10.4 RECENT DEVELOPMENTS
10.10.5 SWOT ANALYSIS
10.11 SERUM INSTITUTE OF INDIA
10.11.1 BUSINESS OVERVIEW
10.11.2 PRODUCTS & SERVICES
10.11.3 KEY STRATEGY
10.11.4 RECENT DEVELOPMENTS
10.11.5 SWOT ANALYSIS
10.12 BAVARIAN NORDIC
10.12.1 BUSINESS OVERVIEW
10.12.2 PRODUCTS & SERVICES
10.12.3 KEY STRATEGY
10.12.4 RECENT DEVELOPMENTS
10.12.5 SWOT ANALYSIS
10.13 MITSUBISHI TANABE PHARMA CORPORATION
10.13.1 BUSINESS OVERVIEW
10.13.2 PRODUCTS & SERVICES
10.13.3 KEY STRATEGY
10.13.4 RECENT DEVELOPMENTS
10.13.5 SWOT ANALYSIS
10.14 DAIICHI SANKYO COMPANY, LIMITED
10.14.1 BUSINESS OVERVIEW
10.14.2 PRODUCTS & SERVICES
10.14.3 KEY STRATEGY
10.14.4 RECENT DEVELOPMENTS
10.14.5 SWOT ANALYSIS